MUMBAI (Reuters) - Japan's Daiichi Sankyo Company Ltd <4568.T> is selling its stake worth up to $3.6 billion in Indian drugmaker Sun Pharmaceutical Industries Ltd , a person directly involved in the deal said on Monday.
The Japanese company is selling its 8.9 percent stake in Sun Pharma, India's largest drugmaker by sales, via block deals on the Indian exchanges, said the person, who declined to be named as he was not authorized to speak to the media.
Mumbai-headquartered Sun Pharma agreed to buy Indian rival Ranbaxy Laboratories Ltd
Daiichi Sankyo said on Monday in an exchange filing that the company's board had approved to sell all or part of its stake in Sun Pharma. The existing business partnership with Sun Pharma will remain unchanged after the deal, it said.
(Reporting by Abhishek Vishnoi; Editing by Sunil Nair)
Relacionados
- Rodríguez destaca que su candidatura la forman personas "capaces y que quieren a Huelva por encima de todo"
- El PSOE de Ayamonte destaca que más del 75% de su programa electoral son aportaciones de ciudadanos
- Junta valora el "hito" que supone la primera voladura de la mina de Riotinto y destaca su compromiso
- La Junta destaca el valor del acueducto romano para dar a conocer la Campiña de Jerez y su turismo
- Andreu destaca que su candidatura "va a trabajar por la decencia" apoyados "por la dignidad de pertenecer al PSOE"
